Skip to content

Effect of postoperative analgesia with Esketamine on perioperative anxiety, depression, and early postoperative recovery quality in patients with gastrointestinal tumors

Effect of postoperative analgesia with Esketamine on perioperative anxiety, depression, and early postoperative recovery quality in patients with gastrointestinal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071304
Enrollment
Unknown
Registered
2023-05-10
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early postoperative recovery quality

Interventions

Esketamine group (Group E):Esketamine group (Group E) analgesic pump plan: Esketamine hydrochloride injection 0.5mg/kg+Dizosin injection 5mg/10kg+Dexmetomidine hydrochloride injection 1.5 µ G/kg+flurb
Control group (Group C):Control group (Group C) analgesic pump plan: Dizosin injection 5mg/10kg+Dexmetomidine hydrochloride injection 1.5 µ G/kg+flurbiprofen axetil injection. The background infusion

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Select patients with gastrointestinal tumors who undergo elective surgical treatment in our hospital; 2) American anesthesiologists (ASA) are classified as Grade I-III; 3) Age 18-65 years old, body mass index (BMI) 18.5-25kg/m ²; 4) Agree to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Emergency surgery; 2) Contraindications for the use of ketamine: patients with aneurysmal vascular disease or arteriovenous malformations, history of cerebral hemorrhage, history of glaucoma, untreated or insufficiently treated hyperthyroidism, and patients with severe risk of hypertension or elevated intracranial pressure; 3) Allergy to Esketamine; 4) Unable to cooperate with research due to mental disorders or mental illnesses; 5) Transferring to ICU after surgery.

Design outcomes

Primary

MeasureTime frame
Hospital anxiety and depression scale;QoR-15;

Countries

China

Contacts

Public ContactHuaqin Liu

The Fourth Hospital of Hebei Medical University

sjzlhq@163.com+86 135 8212 6106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026